The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
Testolone, also known as RAD-140, is a selective androgen receptor modulator (SARM) that is currently being researched for its potential therapeutic applications. It was initially developed to treat conditions such as muscle wasting and osteoporosis.
Testolone works by selectively binding to androgen receptors in the body, particularly in the bones and muscles. By binding to these receptors, it activates them, leading to an increase in protein synthesis and muscle growth. It is believed to have a similar effect to testosterone, but without the negative side effects associated with anabolic steroids.
Additionally, Testolone has shown potential in increasing bone density and strength, which could be beneficial for individuals with osteoporosis or other bone-related conditions.
It is important to note that Testolone is still under investigation and has not been approved for medical use by regulatory authorities. Its use as a performance-enhancing drug or for non-medical purposes is considered illegal and potentially dangerous.